Xin Lü - Concepedia

Author

Xin Lü

Also Known As

Alinoë Lavillaureix, Lee, Tang-Cheng, Lu, Xin, Lu, Xuan, Müller, Christian, TGU Investigators, Tim Ambrose, X Lu, X Q Lu, X. Lu

502

Publications

21.4K

Citations

H-Index

202

Concepts

All Affiliations

Ludwig Cancer Research University of Oxford Imperial College London University College London Ludwig Cancer Research

About

Xin Lü is an author at Ludwig Cancer Research specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	48	84	9.3K
2	Natural Sciences	19	21	1.7K
3	Engineering	8	8	360
4	Arts	1	1	39
5	Health Sciences	1	1	215

Xin Lü

149

Publications

13.4K

Citations

H-Index

Page 1

	Year	Citations
Differential induction of transcriptionally active p53 following UV or lonizing radiation: Defects in chromosome instability syndromes? Xin Lü Cell Differential InductionChromatinGenome InstabilityActive P53Genetics	1993	783
ASPP Proteins Specifically Stimulate the Apoptotic Function of p53 Yardena Samuels-Lev, Daniel O’Connor, Daniele Bergamaschi, Molecular Cell Signal TransductionApoptosisCell DeathApoptotic FunctionTumor Suppressor	2001	657
p53 polymorphism influences response in cancer chemotherapy via modulation of p73-dependent apoptosis Daniele Bergamaschi, Milena Gasco, Louise Hiller, Cancer Cell Tumor BiologyOncologyMedicineApoptosisCell Death	2003	456
iASPP oncoprotein is a key inhibitor of p53 conserved from worm to human Daniele Bergamaschi, Yardena Samuels, Nigel J. O’Neil, Nature Genetics ApoptosisImmunologyCell DeathIaspp OncoproteinTumor Suppressor	2003	373
High level expression of p27 <sup>kip1</sup> and cyclin D1 in some human breast cancer cells: Inverse correlation between the expression of p27 <sup>kip1</sup> and degree of malignancy in human breast and colorectal cancers S Fredersdorf, Jorge S. Burns, Alistair M. Milne, Proceedings of the National Academy of Sciences Breast OncologyChemoprevention StrategyHigh Level P27PathologyCancer Biology	1997	357
Residual Embryonic Cells as Precursors of a Barrett's-like Metaplasia Xia Wang, Hong Ouyang, Yusuke Yamamoto, Cell Cell LineageDevelopmental BiologyCell DivisionCell SpecializationMorphogenesis	2011	326
Specific loss of apoptotic but not cell-cycle arrest function in a human tumor derived p53 mutant. Sheldon Rowan, R Ludwig, Ygal Haupt, The EMBO Journal Tumor BiologySpecific LossOncologyP53 MutantMedicine	1996	301
E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. J.-Kuang Hsieh, S Fredersdorf, Tony Kouzarides, Genes & Development E2f1-induced ApoptosisCell RegulationMedicineApoptosisDirect Interaction	1997	282
<i>Retracted</i>: IL‐6/STAT3 pathway intermediates M1/M2 macrophage polarization during the development of hepatocellular carcinoma Zi Yin, Tingting Ma, Ye Lin, Journal of Cellular Biochemistry	2018	259
iASPP preferentially binds p53 proline-rich region and modulates apoptotic function of codon 72–polymorphic p53 Daniele Bergamaschi, Yardena Samuels, Alexandra Sullivan, Nature Genetics P53 Proline-rich RegionSignal TransductionSignaling PathwayProtein FunctionNatural Sciences	2006	256

Page 1